02/24/2021 5:51 PM | Arrowhead Pharmaceuticals (Issuer) GIVEN DOUGLAS B (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/10/2021 4:56 PM | Arrowhead Pharmaceuticals (Issuer) O'Brien Patrick (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/10/2021 9:30 AM | Arrowhead Pharmaceuticals (Subject) VANGUARD GROUP INC (Filed by)
| Form SC 13G/A
| |
02/04/2021 3:10 PM | Arrowhead Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
02/04/2021 3:05 PM | Arrowhead Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/27/2021 8:54 PM | Arrowhead Pharmaceuticals (Filer)
| Form DEF 14A
| |
01/19/2021 4:58 PM | Arrowhead Pharmaceuticals (Issuer) GIVEN DOUGLAS B (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/15/2021 4:49 PM | Arrowhead Pharmaceuticals (Issuer) Hamilton James C (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/12/2021 5:06 PM | Arrowhead Pharmaceuticals (Issuer) Myszkowski Kenneth Allen (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/08/2021 5:05 PM | Arrowhead Pharmaceuticals (Issuer) Hassard James (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
|
01/07/2021 5:11 PM | Arrowhead Pharmaceuticals (Issuer) O'Brien Patrick (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/07/2021 5:08 PM | Arrowhead Pharmaceuticals (Issuer) Myszkowski Kenneth Allen (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/07/2021 5:02 PM | Arrowhead Pharmaceuticals (Issuer) Hamilton James C (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/05/2021 5:27 PM | Arrowhead Pharmaceuticals (Issuer) Arrowhead Pharmaceuticals (Issuer) O'Brien Patrick (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/05/2021 5:24 PM | Arrowhead Pharmaceuticals (Issuer) Ferrari Mauro (Reporting) Ferrari Mauro (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/05/2021 5:22 PM | Arrowhead Pharmaceuticals (Issuer) Arrowhead Pharmaceuticals (Issuer) De Backer Marianne (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/05/2021 5:20 PM | Arrowhead Pharmaceuticals (Issuer) Myszkowski Kenneth Allen (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/05/2021 5:16 PM | Arrowhead Pharmaceuticals (Issuer) OLUKOTUN ADEOYE Y (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/05/2021 5:14 PM | Arrowhead Pharmaceuticals (Issuer) PERRY MICHAEL S (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/05/2021 5:11 PM | Arrowhead Pharmaceuticals (Issuer) GIVEN DOUGLAS B (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/05/2021 5:07 PM | Arrowhead Pharmaceuticals (Issuer) Hamilton James C (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/05/2021 5:01 PM | Arrowhead Pharmaceuticals (Issuer) Waddill William D. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/04/2021 5:02 PM | Anzalone Christopher Richard (Reporting) Arrowhead Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/30/2020 4:52 PM | Anzalone Christopher Richard (Reporting) Arrowhead Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/29/2020 4:55 PM | Arrowhead Pharmaceuticals (Issuer) GIVEN DOUGLAS B (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/22/2020 4:55 PM | Anzalone Christopher Richard (Reporting) Arrowhead Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/18/2020 5:26 PM | Arrowhead Pharmaceuticals (Issuer) GIVEN DOUGLAS B (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/11/2020 5:16 PM | Arrowhead Pharmaceuticals (Issuer) Waddill William D. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/10/2020 6:07 PM | Anzalone Christopher Richard (Reporting) Arrowhead Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/23/2020 4:58 PM | Arrowhead Pharmaceuticals (Issuer) Bradshaw Curt (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/23/2020 3:34 PM | Arrowhead Pharmaceuticals (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
11/20/2020 5:03 PM | Arrowhead Pharmaceuticals (Issuer) San Martin Javier (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/12/2020 4:49 PM | Arrowhead Pharmaceuticals (Issuer) Myszkowski Kenneth Allen (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/02/2020 5:11 PM | Arrowhead Pharmaceuticals (Issuer) Arrowhead Pharmaceuticals (Issuer) Hamilton James C (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
10/26/2020 5:02 PM | Arrowhead Pharmaceuticals (Issuer) De Backer Marianne (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/23/2020 6:35 PM | Anzalone Christopher Richard (Reporting) Arrowhead Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/22/2020 5:02 PM | Arrowhead Pharmaceuticals (Issuer) Myszkowski Kenneth Allen (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/13/2020 5:01 PM | Arrowhead Pharmaceuticals (Issuer) Ferrari Mauro (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/09/2020 4:00 PM | Arrowhead Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/08/2020 5:31 PM | Arrowhead Pharmaceuticals (Issuer) OLUKOTUN ADEOYE Y (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
09/08/2020 6:35 AM | Arrowhead Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/14/2020 5:08 PM | Anzalone Christopher Richard (Reporting) Arrowhead Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/05/2020 4:14 PM | Arrowhead Pharmaceuticals (Filer)
| Form 424B5
| |
06/26/2020 5:02 PM | Anzalone Christopher Richard (Reporting) Arrowhead Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/24/2020 5:10 PM | Arrowhead Pharmaceuticals (Issuer) De Backer Marianne (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/18/2020 5:27 PM | Arrowhead Pharmaceuticals (Issuer) PERRY MICHAEL S (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/13/2020 5:48 PM | Arrowhead Pharmaceuticals (Issuer) PERRY MICHAEL S (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/13/2020 5:45 PM | Arrowhead Pharmaceuticals (Issuer) Waddill William D. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/29/2020 6:19 PM | Arrowhead Pharmaceuticals (Issuer) GIVEN BRUCE D (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/22/2020 6:00 PM | Arrowhead Pharmaceuticals (Issuer) GIVEN BRUCE D (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/16/2020 6:47 PM | Arrowhead Pharmaceuticals (Issuer) GIVEN DOUGLAS B (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/19/2020 4:18 PM | Arrowhead Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/04/2020 1:47 PM | Arrowhead Pharmaceuticals (Subject) FIRST MANHATTAN CO (Filed by)
| Form SC 13G/A
| |
01/28/2020 3:31 PM | Arrowhead Pharmaceuticals (Filer)
| Form DEF 14A
| |
01/23/2020 5:15 PM | Arrowhead Pharmaceuticals (Issuer) Myszkowski Kenneth Allen (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/14/2020 4:00 PM | Arrowhead Pharmaceuticals (Filer)
| Form PRE 14A
| |
01/13/2020 4:13 PM | Arrowhead Pharmaceuticals (Issuer) Hassard James (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
01/08/2020 5:35 PM | Arrowhead Pharmaceuticals (Issuer) GIVEN BRUCE D (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/08/2020 5:33 PM | Arrowhead Pharmaceuticals (Issuer) O'Brien Patrick (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/08/2020 5:31 PM | Arrowhead Pharmaceuticals (Issuer) Myszkowski Kenneth Allen (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/03/2020 5:10 PM | Arrowhead Pharmaceuticals (Issuer) De Backer Marianne (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/03/2020 5:08 PM | Arrowhead Pharmaceuticals (Issuer) PERRY MICHAEL S (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/03/2020 5:06 PM | Arrowhead Pharmaceuticals (Issuer) Waddill William D. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/03/2020 5:04 PM | Arrowhead Pharmaceuticals (Issuer) GIVEN BRUCE D (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/03/2020 5:02 PM | Arrowhead Pharmaceuticals (Issuer) O'Brien Patrick (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/27/2019 3:54 PM | Anzalone Christopher Richard (Reporting) Arrowhead Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/27/2019 3:51 PM | Arrowhead Pharmaceuticals (Issuer) De Backer Marianne (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
12/13/2019 5:35 PM | Anzalone Christopher Richard (Reporting) Arrowhead Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/04/2019 8:55 PM | Arrowhead Pharmaceuticals (Filer)
| Form 424B5
| |
12/04/2019 5:48 PM | Anzalone Christopher Richard (Reporting) Arrowhead Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/02/2019 3:48 PM | Arrowhead Pharmaceuticals (Filer)
| Form 424B5
| |
12/02/2019 3:02 PM | Arrowhead Pharmaceuticals (Filer)
| Form S-3ASR
| |
11/25/2019 3:11 PM | Arrowhead Pharmaceuticals (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
11/25/2019 3:05 PM | Arrowhead Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/20/2019 5:48 PM | Arrowhead Pharmaceuticals (Issuer) Bradshaw Curt (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
11/20/2019 5:44 PM | Arrowhead Pharmaceuticals (Issuer) San Martin Javier (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
11/07/2019 5:45 PM | Arrowhead Pharmaceuticals (Issuer) Myszkowski Kenneth Allen (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/01/2019 6:32 PM | Arrowhead Pharmaceuticals (Issuer) Myszkowski Kenneth Allen (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/11/2019 6:31 PM | Anzalone Christopher Richard (Reporting) Arrowhead Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/10/2019 9:56 AM | Arrowhead Pharmaceuticals (Subject) VANGUARD GROUP INC (Filed by)
| Form SC 13G
| |
09/27/2019 8:16 PM | Anzalone Christopher Richard (Reporting) Arrowhead Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/24/2019 8:12 PM | Anzalone Christopher Richard (Reporting) Arrowhead Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/11/2019 7:09 PM | Arrowhead Pharmaceuticals (Issuer) PERRY MICHAEL S (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/05/2019 3:09 PM | Arrowhead Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
08/05/2019 3:03 PM | Arrowhead Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/28/2019 6:19 PM | Arrowhead Pharmaceuticals (Issuer) Ferrari Mauro (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/03/2019 5:12 PM | Arrowhead Pharmaceuticals (Issuer) Myszkowski Kenneth Allen (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/29/2019 6:01 PM | Arrowhead Pharmaceuticals (Issuer) O'Brien Patrick (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/29/2019 5:57 PM | Anzalone Christopher Richard (Reporting) Arrowhead Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/22/2019 4:44 PM | Arrowhead Pharmaceuticals (Issuer) Myszkowski Kenneth Allen (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/08/2019 3:12 PM | Arrowhead Pharmaceuticals (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
04/19/2019 4:10 PM | Arrowhead Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/05/2019 5:57 PM | Anzalone Christopher Richard (Reporting) Arrowhead Pharmaceuticals (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/29/2019 3:55 PM | Arrowhead Pharmaceuticals (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/18/2019 2:17 PM | Arrowhead Pharmaceuticals (Filer)
| Form CT ORDER
| |
03/15/2019 4:09 PM | Arrowhead Pharmaceuticals (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/01/2019 7:42 PM | Arrowhead Pharmaceuticals (Issuer) GIVEN BRUCE D (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/27/2019 6:08 PM | Arrowhead Pharmaceuticals (Issuer) GIVEN BRUCE D (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/26/2019 6:32 PM | Arrowhead Pharmaceuticals (Issuer) GIVEN DOUGLAS B (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/20/2019 7:12 PM | Arrowhead Pharmaceuticals (Issuer) Myszkowski Kenneth Allen (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |